Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
NTBLQ similar filings
- 24 Jul 24 Notable Labs Receives FDA Clearance to Proceed Further with Volasertib Phase 2 Study
- 19 Jul 24 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
- 30 May 24 Regulation FD Disclosure
- 6 May 24 Regulation FD Disclosure
- 12 Apr 24 Notable Labs Reports 2023 Financial Results and Provides a Business Update
- 9 Apr 24 Notable Labs Presents the Design Plan for the PPMP-Enabled Phase 2 Trial with Volasertib for Relapsed/Refractory AML at AACR 2024
- 8 Apr 24 Other Events
Filing view
External links